Rectal Artesunate Stakeholders’ Meeting Report

Nairobi, Kenya, 19 February 2016

Medicines for Malaria Venture (MMV), the US President’s Malaria Initiative (PMI), UNICEF and Médecins Sans Frontières (MSF).

8 pp. 303 kB
http://www.mmv.org/sites/default/files/uploads/docs/publications/MMV_RASreport_2
0160513.pdf
Pic 001_resize

On 19 February 2016, stakeholders from 13 organizations spanning the field of malaria prevention and control, seven malaria-endemic countries in Africa and the WHO came together to discuss experiences, challenges and overcoming obstacles relating to the implementation of Rectal Artesunate (RAS) as a pre-referral intervention for the management of severe malaria in children. The meeting was co-convened in Nairobi, Kenya by Medicines for Malaria Venture (MMV), the US President’s Malaria Initiative (PMI), UNICEF and Médecins Sans Frontières (MSF). This report of the RAS Stakeholder Meeting summarises the key issues relating to the adoption and implementation of RAS in malaria-affected regions and outlines recommended actions to speed up access to this life saving medicine.

(Visited 23 times, 1 visits today)
This entry was posted in Essential Medicines, General, Malaria. Bookmark the permalink.